NCT00509691View on ClinicalTrials.gov

Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Cancer
Interventions
BIOLOGICAL

cytomegalovirus pp65-specific cytotoxic T lymphocytes

GENETIC

polymerase chain reaction

OTHER

diagnostic laboratory biomarker analysis

OTHER

flow cytometry

OTHER

immunologic technique

Trial Locations (1)

17033-0850

Penn State Hershey Cancer Institute at Milton S. Hershey Medical Center, Hershey

All Listed Sponsors
collaborator

Penn State University

OTHER

lead

University of Louisville

OTHER

NCT00509691 - Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy | Biotech Hunter | Biotech Hunter